What is The Allstate Corporation's earnings per share (EPS)?

The Allstate Corporation (ALL) reported diluted earnings per share of $38.06 for fiscal year 2025. This represents a 124.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

The Allstate Corporation (ALL) Financials

ALL

Trailing 12 months to June 30, 2026

Revenue $70.1B +5.9% YoY

Net Income $13.3B +129.2% YoY

EPS (Diluted) $50.08 +135.4% YoY

Free Cash Flow $12.2B +43.5% YoY

Market Cap $56.6B as of Oct 3, 2026

Price / Sales 0.8x on $70.1B revenue, trailing 12 months to June 30, 2026

Price / Earnings 4.3x on $13.3B net income, trailing 12 months to June 30, 2026

Price / Book 1.7x on $33.7B equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 3, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 5, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 5, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the ALL SEC filings page.

The Allstate Corporation (ALL) reported $70.1B in revenue over the twelve months to Jun 30, 2026, up 5.9% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI ALL FY2025 2026-10-03

The business shifted from weak profitability to cash-backed earnings while strengthening its equity base and reducing debt dependence.

By FY2025, operating cash flow of $10.1B nearly matched net income of $10.2B, so reported earnings were broadly cash-backed. Free cash flow of $9.9B remained close to operating cash flow because capital expenditures were just $228M, showing that this cash profile required little physical reinvestment in that year.

Revenue grew 18.5% from FY2023 to FY2025, while net margin moved from -0.6% to 15.0%. That divergence points to a major improvement in profitability economics rather than scale alone; the supplied figures do not identify whether mix, pricing, claims, or investment results drove it.

Equity rose from $17.8B in FY2023 to $30.6B in FY2025, giving the balance sheet a larger capital cushion. Over the same span, debt-to-equity fell from 0.4x to 0.2x, meaning the stronger earnings period also left the company less debt-dependent relative to its capital base.

Financial Health Signals

Financial health score not available

The Allstate Corporation does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial

5/7

The Allstate Corporation passes 5 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 3 of 4 profitability signals pass, all 2 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Mixed

0.99x

For every $1 of reported earnings, The Allstate Corporation generates $0.99 in operating cash flow ($10.1B OCF vs $10.2B net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$18.6B

YoY+11.8%

QoQ+9.8%

5Y CAGR+8.0%

10Y CAGR+7.3%

The Allstate Corporation generated $18.6B in revenue in Q2 2026. This represents an increase of 11.8% from the same quarter a year earlier. Against the prior quarter it is up 9.8%.

Net Income

$3.3B

YoY+55.1%

QoQ+33.1%

5Y CAGR+15.0%

10Y CAGR+28.3%

The Allstate Corporation reported $3.3B in net income in Q2 2026. This represents an increase of 55.1% from the same quarter a year earlier. Against the prior quarter it is up 33.1%.

EPS (Diluted)

$12.51

YoY+61.2%

QoQ+35.2%

5Y CAGR+18.9%

10Y CAGR+34.6%

The Allstate Corporation earned $12.51 per diluted share (EPS) in Q2 2026. This represents an increase of 61.2% from the same quarter a year earlier. Against the prior quarter it is up 35.2%.

EBITDA

Not reported for Q2 2026.

Cash & Balance Sheet

Free Cash Flow

$2.6B

YoY+38.4%

QoQ-26.4%

5Y CAGR+13.2%

10Y CAGR+16.2%

The Allstate Corporation generated $2.6B in free cash flow in Q2 2026, representing cash available after capex. This represents an increase of 38.4% from the same quarter a year earlier. Against the prior quarter it is down 26.4%.

Cash & Debt

$840.0M

YoY-15.6%

QoQ+20.5%

5Y CAGR+5.1%

10Y CAGR+6.5%

The Allstate Corporation held $840.0M in cash against $7.5B in long-term debt as of Q2 2026.

Dividends Per Share

$1.08

YoY+8.0%

QoQ0.0%

5Y CAGR+5.9%

10Y CAGR+12.6%

The Allstate Corporation paid $1.08 per share in dividends in Q2 2026. This represents an increase of 8.0% from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding

253M

YoY-4.0%

QoQ-1.8%

5Y CAGR-3.1%

10Y CAGR-3.8%

The Allstate Corporation had 253M shares outstanding in Q2 2026. This represents a decrease of 4.0% from the same quarter a year earlier. Against the prior quarter it is down 1.8%.

Margins & Returns

Net Margin

17.6%

YoY+4.9pp

QoQ+3.1pp

5Y change+4.7pp

10Y change+14.6pp

The Allstate Corporation's net profit margin was 17.6% in Q2 2026, showing the share of revenue converted to profit. This is up 4.9 percentage points from the same quarter a year earlier. Against the prior quarter it is up 3.1 percentage points.

Return on Equity

9.7%

YoY+0.9pp

QoQ+1.9pp

5Y change+4.0pp

10Y change+8.4pp

The Allstate Corporation's ROE was 9.7% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 0.9 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.9 percentage points.

Gross Margin

Not reported for Q2 2026.

Operating Margin

Not reported for Q2 2026.

Capital Allocation

Share Buybacks

$1.1B

YoY+209.1%

QoQ+71.2%

5Y CAGR+13.3%

10Y CAGR+8.9%

The Allstate Corporation spent $1.1B on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. This represents an increase of 209.1% from the same quarter a year earlier. Against the prior quarter it is up 71.2%.

Capital Expenditures

$43.0M

YoY+4200.0%

QoQ+7.5%

5Y CAGR-20.6%

10Y CAGR-4.5%

The Allstate Corporation invested $43.0M in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 4200.0% from the same quarter a year earlier. Against the prior quarter it is up 7.5%.

R&D Spending

Not reported for Q2 2026.

ALL Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ALL quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$70.1B	$67.7B+5.6%	$64.1B+12.3%	$57.1B+11.1%	$51.4B+1.6%	$50.6B+20.7%	$41.9B+0.9%	$41.5B+4.3%	$39.8B+1.0%	$39.4B+5.4%	$37.4B+4.9%	$35.7B+1.2%	$35.2B+2.1%	$34.5B+3.6%	$33.3B+2.0%	$32.7B
Interest Expense	N/A	$399.0M-0.3%	$400.0M+5.5%	$379.0M+13.1%	$335.0M+1.5%	$330.0M+3.8%	$318.0M-2.8%	$327.0M-1.5%	$332.0M-0.9%	$335.0M+13.6%	$295.0M+1.0%	$292.0M-9.3%	$322.0M-12.3%	$367.0M-1.6%	$373.0M+1.6%	$367.0M
Income Tax	N/A	$2.9B+148.7%	$1.2B+960.7%	-$135.0M+72.3%	-$488.0M-137.8%	$1.3B-5.9%	$1.4B+23.0%	$1.1B+138.5%	$468.0M-53.0%	$995.0M+18.2%	$842.0M-24.2%	$1.1B-19.8%	$1.4B+24.2%	$1.1B+11.6%	$1.0B+481.4%	$172.0M
Net Income	$13.3B	$10.2B+123.4%	$4.5B+1539.9%	-$316.0M+77.7%	-$1.4B-195.4%	$1.5B-73.4%	$5.6B+15.0%	$4.8B+124.4%	$2.2B-39.2%	$3.6B+96.6%	$1.8B-16.7%	$2.2B-23.8%	$2.9B+25.0%	$2.3B-1.1%	$2.3B+193.0%	$787.0M
EPS (Basic)	N/A	$38.56+123.9%	$17.22+1535.0%	-$1.20+76.7%	-$5.14-201.0%	$5.09-71.0%	$17.53+23.0%	$14.25+146.5%	$5.78-39.2%	$9.50+109.3%	$4.54-11.3%	$5.12-19.6%	$6.37+30.8%	$4.87+3.4%	$4.71+211.9%	$1.51
EPS (Diluted)	$50.08	$38.06+124.0%	$16.99+1515.8%	-$1.20+76.7%	-$5.14-202.6%	$5.01-71.1%	$17.31+23.4%	$14.03+146.1%	$5.70-39.0%	$9.35+108.7%	$4.48-11.3%	$5.05-19.5%	$6.27+30.4%	$4.81+2.8%	$4.68+212.0%	$1.50
Diluted Shares (Avg)	N/A	267M-0.3%	268M+2.0%	263M-3.2%	271M-9.3%	299M-5.2%	316M-5.4%	334M-5.6%	353M-4.0%	368M-2.5%	377M-7.3%	407M-7.2%	438M-6.8%	470M-4.6%	493M-5.8%	523M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-K	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-K
Revenue	$18.6B+11.8%	$16.9B+3.0%	$17.3B+5.1%	$17.3B+3.8%	$16.6B+5.8%	$16.5B+7.8%	$16.5B+11.3%	$16.6B+14.7%
Interest Expense	$96.0M-4.0%	$98.0M-2.0%	N/A	$101.0M-2.9%	$100.0M+2.0%	$100.0M+3.1%	N/A	$104.0M+18.2%
Income Tax	$871.0M+44.2%	$650.0M+428.5%	N/A	$1.1B+323.2%	$604.0M+627.7%	$123.0M-53.8%	N/A	$254.0M+1594.1%
Net Income	$3.3B+55.1%	$2.5B+312.9%	$3.8B+100.3%	$3.7B+214.8%	$2.1B+537.2%	$595.0M-51.1%	$1.9B+30.1%	$1.2B+23900.0%
EPS (Basic)	$12.66+61.1%	$9.36+339.4%	$14.55+103.2%	$14.13+221.9%	$7.86+589.5%	$2.13-52.8%	$7.16+28.5%	$4.39+2843.8%
EPS (Diluted)	$12.51+61.2%	$9.25+338.4%	$14.37+103.3%	$13.95+222.2%	$7.76+586.7%	$2.11-52.7%	$7.07+28.1%	$4.33
Diluted Shares (Avg)	259M-3.3%	263M-2.3%	N/A	266M-0.6%	268M+0.3%	269M+0.9%	N/A	268M

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA.

ALL Balance Sheet

ALL quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$119.8B+7.3%	$111.6B+8.0%	$103.4B+5.5%	$98.0B-1.5%	$99.4B-21.1%	$126.0B+5.0%	$120.0B+6.9%	$112.2B-0.2%	$112.4B+3.5%	$108.6B+3.8%	$104.7B-3.5%	$108.5B-12.1%	$123.5B-2.7%	$126.9B+1.4%	$125.2B
Cash & Equivalents	$678.0M-3.7%	$704.0M-2.5%	$722.0M-1.9%	$736.0M-3.5%	$763.0M+145.3%	$311.0M+13.9%	$273.0M-35.8%	$425.0M-31.1%	$617.0M+41.5%	$436.0M-11.9%	$495.0M-24.7%	$657.0M-2.7%	$675.0M-16.3%	$806.0M+3.9%	$776.0M
Short-Term Investments	$4.9B+7.7%	$4.5B-11.8%	$5.1B+23.3%	$4.2B+4.1%	$4.0B-41.1%	$6.8B+59.8%	$4.3B+40.7%	$3.0B+55.7%	$1.9B-54.7%	$4.3B+102.1%	$2.1B-16.5%	$2.5B+6.1%	$2.4B+2.4%	$2.3B+80.9%	$1.3B
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$3.1B-3.9%	$3.2B-7.3%	$3.5B0.0%	$3.5B0.0%	$3.5B+47.8%	$2.4B-6.9%	$2.5B+0.6%	$2.5B+16.0%	$2.2B+78.9%	$1.2B0.0%	$1.2B0.0%	$1.2B-1.9%	$1.2B+0.2%	$1.2B-0.2%	$1.2B
Total Liabilities	$89.2B-1.2%	$90.3B+5.3%	$85.7B+6.3%	$80.6B+8.5%	$74.3B-22.4%	$95.8B+1.9%	$94.0B+3.3%	$90.9B+1.2%	$89.9B+2.1%	$88.0B+4.0%	$84.6B-1.8%	$86.2B-15.5%	$102.0B-4.1%	$106.4B-0.5%	$106.9B
Long-Term Debt	$7.5B-7.4%	$8.1B+1.8%	$7.9B-0.3%	$8.0B-0.2%	$8.0B+1.9%	$7.8B+18.0%	$6.6B+2.8%	$6.5B+1.6%	$6.3B0.0%	$6.3B+23.9%	$5.1B-0.3%	$5.1B-17.1%	$6.2B+2.4%	$6.1B+2.5%	$5.9B
Total Equity	$30.6B+42.8%	$21.4B+20.7%	$17.8B+1.6%	$17.5B-29.9%	$24.9B-17.5%	$30.2B+16.2%	$26.0B+22.0%	$21.3B-5.5%	$22.6B+9.6%	$20.6B+2.7%	$20.0B-10.2%	$22.3B+3.8%	$21.5B+4.4%	$20.6B+12.5%	$18.3B
Retained Earnings	$62.4B+17.1%	$53.3B+7.2%	$49.7B-2.5%	$51.0B-4.4%	$53.3B+1.0%	$52.8B+9.8%	$48.1B+9.2%	$44.0B+5.9%	$41.6B+2.2%	$40.7B+3.2%	$39.4B+4.2%	$37.8B+6.4%	$35.6B+5.3%	$33.8B+5.9%	$31.9B

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-K	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-K
Total Assets	$124.8B+7.6%	$124.0B+7.7%	$119.8B+7.3%	$120.4B+5.9%	$115.9B+6.9%	$115.2B+9.4%	$111.6B+8.0%	$113.7B+12.4%
Cash & Equivalents	$840.0M-15.6%	$697.0M-17.0%	$678.0M-3.7%	$931.0M+14.1%	$995.0M+66.1%	$840.0M-1.2%	$704.0M-2.5%	$816.0M-5.1%
Short-Term Investments	$4.9B-49.5%	$4.7B-28.1%	$4.9B+7.7%	$8.7B+25.0%	$9.6B+82.3%	$6.5B+51.5%	$4.5B-11.8%	$7.0B+107.7%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$3.1B0.0%	$3.1B+0.1%	$3.1B-3.9%	$3.1B-2.7%	$3.1B-11.0%	$3.1B-11.1%	$3.2B-7.3%	$3.2B-8.5%
Total Liabilities	$91.1B-0.9%	$92.4B-0.8%	$89.2B-1.2%	$92.9B0.0%	$91.9B+2.3%	$93.1B+7.3%	$90.3B+5.3%	$92.9B+7.1%
Long-Term Debt	$7.5B-7.4%	$7.5B-7.4%	$7.5B-7.4%	$8.1B+0.1%	$8.1B+0.1%	$8.1B+1.9%	$8.1B+1.8%	$8.1B+1.7%
Total Equity	$33.7B+40.3%	$31.6B+43.3%	$30.6B+42.8%	$27.5B+31.7%	$24.0B+29.2%	$22.1B+18.3%	$21.4B+20.7%	$20.9B+43.1%
Retained Earnings	$67.5B+21.8%	$64.5B+20.4%	$62.4B+17.1%	$58.9B+14.0%	$55.4B+9.2%	$53.6B+5.8%	$53.3B+7.2%	$51.6B+6.5%

Not reported in any period shown, so not listed: Current Assets, Inventory, Accounts Receivable, Current Liabilities, Non-Current Liabilities.

ALL Cash Flow Statement

ALL quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$12.5B	$10.1B+13.2%	$8.9B+111.2%	$4.2B-17.4%	$5.1B+0.1%	$5.1B-6.8%	$5.5B+7.1%	$5.1B-0.9%	$5.2B+20.0%	$4.3B+8.0%	$4.0B+10.4%	$3.6B+11.7%	$3.2B-23.7%	$4.2B+38.9%	$3.1B+58.3%	$1.9B
Depreciation & Amortization	N/A	$482.0M-13.2%	$555.0M-21.2%	$704.0M-16.9%	$847.0M-22.0%	$1.1B+58.3%	$686.0M+6.0%	$647.0M+26.6%	$511.0M+5.8%	$483.0M+26.4%	$382.0M+3.0%	$371.0M+1.4%	$366.0M-0.5%	$368.0M-5.2%	$388.0M+54.0%	$252.0M
Stock-Based Compensation	N/A	$123.0M-1.6%	$125.0M+71.2%	$73.0M-21.5%	$93.0M-22.5%	$120.0M-3.2%	$124.0M+18.1%	$105.0M-16.0%	$125.0M+17.9%	$106.0M+32.5%	$80.0M-1.2%	$81.0M-8.0%	$88.0M-5.4%	$93.0M+8.1%	$86.0M+34.4%	$64.0M
Capital Expenditures	$220.0M	$228.0M+8.6%	$210.0M-21.3%	$267.0M-36.4%	$420.0M+21.7%	$345.0M+12.0%	$308.0M-28.9%	$433.0M+56.3%	$277.0M-7.4%	$299.0M-4.5%	$313.0M+3.3%	$303.0M+5.2%	$288.0M+39.1%	$207.0M-27.4%	$285.0M+15.9%	$246.0M
Free Cash Flow	$12.2B	$9.9B+13.3%	$8.7B+120.2%	$4.0B-15.7%	$4.7B-1.5%	$4.8B-7.9%	$5.2B+10.4%	$4.7B-4.1%	$4.9B+22.0%	$4.0B+9.1%	$3.7B+11.1%	$3.3B+12.4%	$2.9B-26.9%	$4.0B+45.7%	$2.8B+64.5%	$1.7B
Investing Cash Flow	-$8.5B	-$7.3B+12.1%	-$8.3B-175.2%	-$3.0B-73.6%	-$1.7B-438.8%	$510.0M+114.8%	-$3.4B-22.6%	-$2.8B-63.3%	-$1.7B-42.1%	-$1.2B+52.1%	-$2.5B-440.4%	$742.0M-54.2%	$1.6B+2.6%	$1.6B-0.1%	$1.6B-74.3%	$6.2B
Financing Cash Flow	-$4.2B	-$2.9B-313.3%	-$697.0M+43.9%	-$1.2B+63.7%	-$3.4B+34.7%	-$5.2B-160.6%	-$2.0B+19.0%	-$2.5B+30.5%	-$3.6B-22.3%	-$2.9B-91.5%	-$1.5B+66.2%	-$4.5B+7.3%	-$4.9B+18.1%	-$6.0B-29.3%	-$4.6B+41.5%	-$7.9B
Dividends Paid	$1.1B	$1.0B+7.7%	$962.0M+4.0%	$925.0M-0.1%	$926.0M+4.6%	$885.0M+32.5%	$668.0M+2.3%	$653.0M+6.4%	$614.0M+17.0%	$525.0M+8.0%	$486.0M+0.6%	$483.0M+1.3%	$477.0M+35.5%	$352.0M-34.1%	$534.0M+22.8%	$435.0M
Share Buybacks	$2.5B	$1.2B+61550.0%	$2.0M-99.4%	$335.0M-86.7%	$2.5B-19.2%	$3.1B+79.6%	$1.7B+0.1%	$1.7B-24.7%	$2.3B+54.0%	$1.5B+11.8%	$1.3B-52.4%	$2.8B+22.0%	$2.3B+25.5%	$1.8B+100.9%	$913.0M-4.2%	$953.0M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-K	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-K
Operating Cash Flow	$2.6B+40.6%	$3.6B+81.4%	$3.0B+75.3%	$3.3B+2.6%	$1.9B-20.6%	$2.0B+17.9%	$1.7B+39.2%	$3.2B+159.6%
Depreciation & Amortization	$86.0M-32.3%	$101.0M-23.5%	$108.0M-28.5%	$115.0M-17.9%	$127.0M-3.8%	$132.0M0.0%	$151.0M-8.5%	$140.0M-20.5%
Capital Expenditures	$43.0M+4200.0%	$40.0M-56.5%	$89.0M+78.0%	$48.0M-23.8%	-$1.0M-98.2%	$92.0M+124.4%	$50.0M-29.6%	$63.0M+14.5%
Free Cash Flow	$2.6B+38.4%	$3.5B+88.1%	$2.9B+75.2%	$3.2B+3.1%	$1.9B-18.7%	$1.9B+15.2%	$1.7B+43.4%	$3.1B+166.4%
Investing Cash Flow	-$1.2B+3.9%	-$2.6B-103.2%	-$1.9B-16.6%	-$2.8B-4.5%	-$1.2B+52.1%	-$1.3B+5.8%	-$1.7B-51.2%	-$2.7B-217.8%
Financing Cash Flow	-$1.3B-114.5%	-$916.0M-174.3%	-$1.3B-397.3%	-$634.0M-242.7%	-$620.0M-620.9%	-$334.0M-101.2%	-$260.0M-0.8%	-$185.0M+18.5%
Dividends Paid	$280.0M+5.7%	$261.0M+7.0%	$263.0M+8.2%	$264.0M+8.6%	$265.0M+9.1%	$244.0M+4.7%	$243.0M+4.3%	$243.0M+4.3%
Share Buybacks	$1.1B+209.1%	$614.0M+520.2%	$434.0M+21600.0%	$360.0M	$340.0M	$99.0M	$2.0M	$0-100.0%

Not reported in any period shown, so not listed: Stock-Based Compensation.

ALL Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ALL quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Net Margin	15.0%+7.9pp	7.1%+7.6pp	-0.5%+2.2pp	-2.8%-5.7pp	2.9%-10.4pp	13.3%+1.6pp	11.7%+6.2pp	5.4%-3.6pp	9.0%+4.2pp	4.8%-1.3pp	6.1%-2.0pp	8.1%+1.5pp	6.6%-0.3pp	6.9%+4.5pp	2.4%
Return on Equity	33.2%+12.0pp	21.2%+23.0pp	-1.8%+6.3pp	-8.1%-14.1pp	5.9%-12.5pp	18.4%-0.2pp	18.6%+8.5pp	10.1%-5.6pp	15.8%+7.0pp	8.8%-2.0pp	10.8%-1.9pp	12.8%+2.2pp	10.6%-0.6pp	11.2%+6.9pp	4.3%
Return on Assets	8.5%+4.4pp	4.1%+4.4pp	-0.3%+1.1pp	-1.5%-2.9pp	1.5%-2.9pp	4.4%+0.4pp	4.0%+2.1pp	1.9%-1.2pp	3.2%+1.5pp	1.7%-0.4pp	2.1%-0.6pp	2.6%+0.8pp	1.8%0.0pp	1.8%+1.2pp	0.6%
Debt-to-Equity	0.24-0.1x	0.38-0.1x	0.450.0x	0.46+0.1x	0.32+0.1x	0.260.0x	0.260.0x	0.300.0x	0.280.0x	0.31+0.1x	0.260.0x	0.23-0.1x	0.290.0x	0.290.0x	0.32
Asset Turnover	0.570.0x	0.570.0x	0.550.0x	0.520.0x	0.51+0.2x	0.330.0x	0.350.0x	0.350.0x	0.350.0x	0.340.0x	0.340.0x	0.320.0x	0.280.0x	0.260.0x	0.26
FCF Margin	14.6%+1.0pp	13.6%+6.7pp	6.9%-2.2pp	9.1%-0.3pp	9.4%-2.9pp	12.4%+1.1pp	11.3%-1.0pp	12.3%+2.1pp	10.2%+0.4pp	9.8%+0.6pp	9.3%+0.9pp	8.4%-3.3pp	11.7%+3.4pp	8.3%+3.2pp	5.1%

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-K	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-K
Net Margin	17.6%+4.9pp	14.5%+10.9pp	21.9%+10.4pp	21.7%+14.5pp	12.7%+10.6pp	3.6%-4.4pp	11.5%+1.7pp	7.2%+7.2pp
Return on Equity	9.7%+0.9pp	7.8%+5.1pp	12.4%+3.6pp	13.6%+7.9pp	8.8%+7.0pp	2.7%-3.8pp	8.9%+0.6pp	5.7%+5.7pp
Return on Assets	2.6%+0.8pp	2.0%+1.5pp	3.2%+1.5pp	3.1%+2.1pp	1.8%+1.5pp	0.5%-0.6pp	1.7%+0.3pp	1.1%+1.1pp
Debt-to-Equity	0.22-0.1x	0.24-0.1x	0.24-0.1x	0.29-0.1x	0.34-0.1x	0.37-0.1x	0.38-0.1x	0.39-0.2x
Asset Turnover	0.150.0x	0.140.0x	0.140.0x	0.140.0x	0.140.0x	0.140.0x	0.150.0x	0.150.0x
FCF Margin	13.9%+2.7pp	20.8%+9.4pp	16.7%+6.7pp	18.8%-0.1pp	11.3%-3.4pp	11.4%+0.7pp	10.0%+2.3pp	18.9%+10.7pp

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Current Ratio.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
The Allstate Corporation ALL	FY2025	$67.7B	$10.2B	15.0%	$56.6B	—
The Travelers Companies, Inc. TRV	FY2025	$48.8B	$6.3B	12.9%	$75.2B	46/100
The Hartford Insurance Group, Inc. HIG	FY2025	$28.4B	$3.8B	13.5%	$34.1B	36/100
Chubb Limited CB	FY2025	$59.4B	$10.3B	17.4%	$127.7B	59/100
W.R. Berkley Corporation WRB	FY2025	$14.7B	$1.8B	12.1%	$25.6B	52/100
Markel Group Inc. MKL	FY2025	$15.5B	$2.1B	13.6%	$21.5B	24/100

Where The Allstate Corporation Ranks

Frequently Asked Questions

What is The Allstate Corporation's annual revenue?

The Allstate Corporation (ALL) reported $67.7B in total revenue for fiscal year 2025. This represents a 5.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is The Allstate Corporation's revenue growing?

The Allstate Corporation (ALL) revenue grew by 5.6% year-over-year, from $64.1B to $67.7B in fiscal year 2025.

Is The Allstate Corporation profitable?

Yes, The Allstate Corporation (ALL) reported a net income of $10.2B in fiscal year 2025, with a net profit margin of 15.0%.

How much debt does The Allstate Corporation have?

As of fiscal year 2025, The Allstate Corporation (ALL) had $678.0M in cash and equivalents against $7.5B in long-term debt.

What is The Allstate Corporation's net profit margin?

The Allstate Corporation (ALL) had a net profit margin of 15.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does The Allstate Corporation pay dividends?

Yes, The Allstate Corporation (ALL) paid $4.00 per share in dividends during fiscal year 2025.

What is The Allstate Corporation's return on equity (ROE)?

The Allstate Corporation (ALL) has a return on equity of 33.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is The Allstate Corporation's free cash flow?

The Allstate Corporation (ALL) generated $9.9B in free cash flow during fiscal year 2025. This represents a 13.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is The Allstate Corporation's operating cash flow?

The Allstate Corporation (ALL) generated $10.1B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are The Allstate Corporation's total assets?

The Allstate Corporation (ALL) had $119.8B in total assets as of fiscal year 2025, including both current and long-term assets.

What are The Allstate Corporation's capital expenditures?

The Allstate Corporation (ALL) invested $228.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Does The Allstate Corporation buy back shares?

Yes, The Allstate Corporation (ALL) spent $1.2B on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does The Allstate Corporation have outstanding?

The Allstate Corporation (ALL) had 260M shares outstanding as of fiscal year 2025.

What is The Allstate Corporation's debt-to-equity ratio?

The Allstate Corporation (ALL) had a debt-to-equity ratio of 0.24 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is The Allstate Corporation's return on assets (ROA)?

The Allstate Corporation (ALL) had a return on assets of 8.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is The Allstate Corporation's P/E ratio?

The Allstate Corporation (ALL) trades at 4.3x earnings, its market capitalization divided by net income of $13.3B net income, trailing 12 months to June 30, 2026. The market capitalization is $56.6B as of Oct 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is The Allstate Corporation's price-to-sales ratio?

The Allstate Corporation (ALL) trades at 0.8x sales, its market capitalization divided by revenue of $70.1B revenue, trailing 12 months to June 30, 2026. The market capitalization is $56.6B as of Oct 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is The Allstate Corporation's Piotroski F-Score?

The Allstate Corporation (ALL) has a Piotroski F-Score of 5 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are The Allstate Corporation's earnings high quality?

The Allstate Corporation (ALL) has an earnings quality ratio of 0.99x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.